Stay updated with breaking news from Aaron Ondrey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Advanced RP-L102 for Fanconi Anemia towards regulatory reviews; EMA accepted MAA for review and BLA submission anticipated in the first half of 2024 Continued preparations to launch LV portfolio...
“Quiet cutting is just not the right thing to do, plain and simple," says career expert Vicki Salemi.
Rocket Pharmaceuticals (RCKT) has shared an announcement. Rocket Pharmaceuticals, Inc. has appointed Aaron Ondrey as their new Chief Financial Offi...
AI can be used to improve strategic measurement and outcomes, according to researchers.
Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced the appointment of Aaron Ondrey, as Chief Financial...